Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in Mexico
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.2026
https://www.valueinhealthjournal.com/article/S1098-3015(13)03938-7/fulltext
Title :
Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in Mexico
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03938-7&doi=10.1016/j.jval.2013.08.2026
First page :
A684
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1851